Literature DB >> 25791923

Flavanone silibinin treatment attenuates nitrogen mustard-induced toxic effects in mouse skin.

Anil K Jain1, Neera Tewari-Singh1, Swetha Inturi1, Dileep Kumar1, David J Orlicky2, Chapla Agarwal1, Carl W White3, Rajesh Agarwal4.   

Abstract

Currently, there is no effective antidote to prevent skin injuries by sulfur mustard (SM) and nitrogen mustard (NM), which are vesicating agents with potential relevance to chemical warfare, terrorist attacks, or industrial/laboratory accidents. Our earlier report has demonstrated the therapeutic efficacy of silibinin, a natural flavanone, in reversing monofunctional alkylating SM analog 2-chloroethyl ethyl sulfide-induced toxic effects in mouse skin. To translate this effect to a bifunctional alkylating vesicant, herein, efficacy studies were carried out with NM. Topical application of silibinin (1 or 2mg) 30 min after NM exposure on the dorsal skin of male SKH-1 hairless mice significantly decreased NM-induced toxic lesions at 24, 72 or 120 h post-exposure. Specifically, silibinin treatment resulted in dose-dependent reduction of NM-induced increase in epidermal thickness, dead and denuded epidermis, parakeratosis and microvesication. Higher silibinin dose also caused a 79% and 51%reversal in NM-induced increases in myeloperoxidase activity and COX-2 levels, respectively. Furthermore, silibinin completely prevented NM-induced H2A.X phosphorylation, indicating reversal of DNA damage which could be an oxidative DNA damage as evidenced by high levels of 8-oxodG in NM-exposed mouse skin that was significantly reversed by silibinin. Together, these findings suggest that attenuation of NM-induced skin injury by silibinin is due to its effects on the pathways associated with DNA damage, inflammation, vesication and oxidative stress. In conclusion, results presented here support the optimization of silibinin as an effective treatment of skin injury by vesicants.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Microvesication; Nitrogen mustard; Oxidative DNA damage; SKH-1 hairless mice; Silibinin; Skin

Mesh:

Substances:

Year:  2015        PMID: 25791923      PMCID: PMC4410080          DOI: 10.1016/j.taap.2015.03.009

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  40 in total

Review 1.  Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent.

Authors:  Shahriar Khateri; Mostafa Ghanei; Saeed Keshavarz; Mohammad Soroush; David Haines
Journal:  J Occup Environ Med       Date:  2003-11       Impact factor: 2.162

Review 2.  Efficacy of glutathione in ameliorating sulfur mustard analog-induced toxicity in cultured skin epidermal cells and in SKH-1 mouse skin in vivo.

Authors:  Neera Tewari-Singh; Chapla Agarwal; Jie Huang; Brian J Day; Carl W White; Rajesh Agarwal
Journal:  J Pharmacol Exp Ther       Date:  2010-10-25       Impact factor: 4.030

3.  Long-term skin damage due to chemical weapon exposure.

Authors:  Alireza Firooz; Bardia Sadr; Seyed M Davoudi; Mansour Nassiri-Kashani; Yunes Panahi; Yahya Dowlati
Journal:  Cutan Ocul Toxicol       Date:  2010-11-04       Impact factor: 1.820

4.  Time course of lesion development in the hairless guinea-pig model of sulfur mustard-induced dermal injury.

Authors:  Janet M Benson; JeanClare Seagrave; Waylon M Weber; Colleen D Santistevan; Gary R Grotendorst; Gregory S Schultz; Thomas H March
Journal:  Wound Repair Regen       Date:  2011-03-16       Impact factor: 3.617

5.  Sulfur mustard analog, 2-chloroethyl ethyl sulfide-induced skin injury involves DNA damage and induction of inflammatory mediators, in part via oxidative stress, in SKH-1 hairless mouse skin.

Authors:  Anil K Jain; Neera Tewari-Singh; Mallikarjuna Gu; Swetha Inturi; Carl W White; Rajesh Agarwal
Journal:  Toxicol Lett       Date:  2011-06-21       Impact factor: 4.372

6.  Therapeutic potential of a non-steroidal bifunctional anti-inflammatory and anti-cholinergic agent against skin injury induced by sulfur mustard.

Authors:  Yoke-Chen Chang; James D Wang; Rita A Hahn; Marion K Gordon; Laurie B Joseph; Diane E Heck; Ned D Heindel; Sherri C Young; Patrick J Sinko; Robert P Casillas; Jeffrey D Laskin; Debra L Laskin; Donald R Gerecke
Journal:  Toxicol Appl Pharmacol       Date:  2014-08-13       Impact factor: 4.219

7.  2-Chloroethyl ethyl sulfide causes microvesication and inflammation-related histopathological changes in male hairless mouse skin.

Authors:  Anil K Jain; Neera Tewari-Singh; David J Orlicky; Carl W White; Rajesh Agarwal
Journal:  Toxicology       Date:  2011-02-02       Impact factor: 4.221

8.  Medical management of cutaneous sulfur mustard injuries.

Authors:  John S Graham; Robert S Stevenson; Larry W Mitcheltree; Tracey A Hamilton; Robin R Deckert; Robyn B Lee; Ann M Schiavetta
Journal:  Toxicology       Date:  2008-08-14       Impact factor: 4.221

9.  Amelioration of sulfur mustard skin injury following a topical treatment with a mixture of a steroid and a NSAID.

Authors:  Shlomit Dachir; Eliezer Fishbeine; Yakov Meshulam; Rita Sahar; Shira Chapman; Adina Amir; Tamar Kadar
Journal:  J Appl Toxicol       Date:  2004 Mar-Apr       Impact factor: 3.446

10.  Effects of iodine on inducible nitric oxide synthase and cyclooxygenase-2 expression in sulfur mustard-induced skin.

Authors:  A Nyska; L Lomnitski; R Maronpot; C Moomaw; B Brodsky; A Sintov; U Wormser
Journal:  Arch Toxicol       Date:  2001-02       Impact factor: 5.153

View more
  9 in total

Review 1.  Antioxidants as potential medical countermeasures for chemical warfare agents and toxic industrial chemicals.

Authors:  Cameron S McElroy; Brian J Day
Journal:  Biochem Pharmacol       Date:  2015-10-22       Impact factor: 5.858

Review 2.  Corneal toxicity induced by vesicating agents and effective treatment options.

Authors:  Dinesh G Goswami; Neera Tewari-Singh; Rajesh Agarwal
Journal:  Ann N Y Acad Sci       Date:  2016-06-21       Impact factor: 5.691

Review 3.  Mustard vesicating agent-induced toxicity in the skin tissue and silibinin as a potential countermeasure.

Authors:  Neera Tewari-Singh; Rajesh Agarwal
Journal:  Ann N Y Acad Sci       Date:  2016-06-21       Impact factor: 5.691

Review 4.  Sulfur mustard inhalation: mechanisms of injury, alteration of coagulation, and fibrinolytic therapy.

Authors:  Carl W White; Raymond C Rancourt; Livia A Veress
Journal:  Ann N Y Acad Sci       Date:  2016-07-06       Impact factor: 5.691

5.  Mitigation of nitrogen mustard mediated skin injury by a novel indomethacin bifunctional prodrug.

Authors:  Gabriella M Composto; Jeffrey D Laskin; Debra L Laskin; Donald R Gerecke; Robert P Casillas; Ned D Heindel; Laurie B Joseph; Diane E Heck
Journal:  Exp Mol Pathol       Date:  2016-05-14       Impact factor: 3.362

6.  Defining the timing of 25(OH)D rescue following nitrogen mustard exposure.

Authors:  Lopa M Das; Amy M Binko; Zachary P Traylor; Lori Duesler; Kurt Q Lu
Journal:  Cutan Ocul Toxicol       Date:  2017-08-08       Impact factor: 1.820

7.  Targeting TRPV1-mediated autophagy attenuates nitrogen mustard-induced dermal toxicity.

Authors:  Mingliang Chen; Xunhu Dong; Haoyue Deng; Feng Ye; Yuanpeng Zhao; Jin Cheng; Guorong Dan; Jiqing Zhao; Yan Sai; Xiuwu Bian; Zhongmin Zou
Journal:  Signal Transduct Target Ther       Date:  2021-01-25

8.  Vitamin D3 ameliorates nitrogen mustard-induced cutaneous inflammation by inactivating the NLRP3 inflammasome through the SIRT3-SOD2-mtROS signaling pathway.

Authors:  Xunhu Dong; Ying He; Feng Ye; Yuanpeng Zhao; Jin Cheng; Jingsong Xiao; Wenpei Yu; Jiqing Zhao; Yan Sai; Guorong Dan; Mingliang Chen; Zhongmin Zou
Journal:  Clin Transl Med       Date:  2021-02

Review 9.  Use of Some Asteraceae Plants for the Treatment of Wounds: From Ethnopharmacological Studies to Scientific Evidences.

Authors:  Alexsander R Carvalho; Roseana M Diniz; Mariela A M Suarez; Cristiane S S E S Figueiredo; Adrielle Zagmignan; Marcos A G Grisotto; Elizabeth S Fernandes; Luís C N da Silva
Journal:  Front Pharmacol       Date:  2018-08-21       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.